(Q54383762)

English

Combination use of anti-CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicity.

scientific article

Statements

Combination use of anti-CD133 antibody and SSA lectin can effectively enrich cells with high tumorigenicity (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit